Antitumor and antimitogenic properties of cis-dichloro(dipyridine)platinum(II).
نویسندگان
چکیده
منابع مشابه
Binding of an antitumor platinum compound to cells as influenced by physical factors and pharmacologically active agents.
' Aided by Research Grant CA-11811 from the NIH and by research funds from the United States Veterans Administration. 2 The abbreviations used are: c/s-Ptll, cw-dichlorodiammineplatinum(H) (NSC 119875); c/s-PPC, m-dichloro(dipyridine)platinum (II); EATC, Ehrlich ascites tumor cells; TCA, trichloroacetic acid; HN2, nitrogen mustard; DMSO, dimethyl sulfoxide; MEM, Eagle's minimum essential medium...
متن کاملStructure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(II) compounds with sulfur and phosphorus donors.
Twelve Pt(II) complexes with cis-PtP(2)S(2) pharmacophores (where P(2) refers to two monodentate or one bidentate phosphane ligand and S(2) is a dithiolato ligand) were prepared, characterized and evaluated as potential antiproliferative agents. The various compounds were first studied from the structural point of view; afterward, their solubility properties as well as their solution behaviour ...
متن کاملAscorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs.
Dichloro-1,2-diaminocyclohexane (DACH):platinum(II), the prototype DACH:platinum complex, had good antitumor activity, was not cross-resistant with cis-dichlorodiammineplatinum(II) (DDP), but was, unfortunately, virtually insoluble in water and was, therefore, not evaluated clinically. This paper summarizes some of the chemical and biological attributes of a series of cis-bisascorbato-DACH:plat...
متن کاملA phase II study of iproplatin in advanced or metastatic stomach cancer. The EORTC Early Clinical Trial Group.
INTRODUCTION CISPLATIN has been shown to have some activity in gastric cancer but its application is limited because of toxicity [ 11. In recent years, the search for platinum compounds with reduced toxicity has been the main goal in the development of platinum analogs. Based on available phase I data [2, 31, our group decided to evaluate the antitumor activity of the non-nephroand neurotoxic p...
متن کاملSynthesis of Cis-Diammine (1,1-cyclobutane dicarboxylate) Platinum(II)
Platinum-based anticancer drugs are chemotherapeutic agents to treat cancer. Carboplatin (cis diammine cyclobutane dicarboxylate platinum (II)) is a second generation drug that has less toxic than cisplatin, allowing for high dosages. In the first stage, 1,3-Cyclobutane dicarboxylic acid, a key intermediate for the preparation of carboplatin, have been synthesized in good yields using diffe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Cancer research
دوره 31 7 شماره
صفحات -
تاریخ انتشار 1971